| 1st May 2019 7:00 am |
GNW |
Verona Pharma plc ("Verona" or the "Company") Appointment of Nominated Adviser and UK Broker |
| 25th Apr 2019 12:07 pm |
GNW |
Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019 |
| 4th Apr 2019 7:00 am |
GNW |
Grant of Options and RSUs and PDMR Dealings |
| 26th Mar 2019 7:00 am |
GNW |
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference |
| 25th Mar 2019 7:00 am |
GNW |
PDMR Dealing |
| 22nd Mar 2019 4:00 pm |
GNW |
2018 Annual Report and Accounts and Notice of AGM |
| 11th Mar 2019 9:48 am |
GNW |
PDMR Dealing |
| 7th Mar 2019 8:14 am |
GNW |
PDMR Dealing |
| 5th Mar 2019 9:48 am |
GNW |
PDMR Dealing |
| 4th Mar 2019 7:00 am |
GNW |
Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD |
| 28th Feb 2019 7:00 am |
GNW |
Verona Pharma to Present at Cowen and Company 39th Annual Health Care Conference |
| 26th Feb 2019 7:00 am |
GNW |
Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update |
| 20th Feb 2019 7:00 am |
GNW |
Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update |
| 4th Feb 2019 7:00 am |
GNW |
Verona Pharma to Present at Upcoming Investor Conferences |
| 14th Jan 2019 7:00 am |
GNW |
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment |
| 9th Jan 2019 1:00 pm |
GNW |
Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554 |
| 17th Dec 2018 5:20 pm |
GNW |
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD |
| 17th Dec 2018 7:00 am |
GNW |
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD |
| 6th Nov 2018 7:00 am |
GNW |
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2018 |
| 31st Oct 2018 7:00 am |
GNW |
Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment |
| 30th Oct 2018 6:00 am |
GNW |
Verona Pharma to Announce Interim Results for Nine Months Ended September 30, 2018 and Provide Clinical Development Update |
| 26th Oct 2018 10:12 am |
GNW |
Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference |
| 27th Sep 2018 7:00 am |
GNW |
Verona Pharma to Host Investor & Analyst R&D Forum on October 12, 2018 |
| 13th Sep 2018 1:00 pm |
GNW |
Verona Pharma to Host Conference Call to Review Expanded Dataset from RPL554 Phase 2b Clinical Trial in COPD Presented at European Respiratory Society International Congress |
| 7th Aug 2018 7:00 am |
GNW |
Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2018 |
| 2nd Mar 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 2nd Mar 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 30th May 2017 7:00 am |
RNS |
Holding(s) in Company |
| 30th May 2017 7:00 am |
RNS |
Holding(s) in Company |
| 25th May 2017 5:27 pm |
RNS |
Holding(s) in Company |
| 23rd May 2017 8:44 am |
RNS |
Holding(s) in Company |
| 16th May 2017 7:44 am |
RNS |
Partial Exercise of Over-Allotment Option |
| 9th May 2017 3:36 pm |
RNS |
Holding(s) in Company |
| 8th May 2017 5:33 pm |
RNS |
Holding(s) in Company |
| 5th May 2017 3:32 pm |
RNS |
Holding(s) in Company |
| 5th May 2017 12:15 pm |
RNS |
Holding(s) in Company |
| 5th May 2017 11:36 am |
RNS |
Holding(s) in Company |
| 3rd May 2017 6:02 pm |
RNS |
Holding(s) in Company |
| 3rd May 2017 2:49 pm |
RNS |
Block Listing Application and Review |
| 3rd May 2017 12:34 pm |
RNS |
Grant of Options and RSUs and PDMR Dealings |
